Skip to main content
. 2025 Oct 24;17(11):1417. doi: 10.3390/v17111417
EMA European Medicines Agency
FDA Food and Drug Administration
LEN Lenacapavir
PLWH People living with HIV
CVF Confirmed virologic failure
LA Long-acting
ISR Injection site reaction
TND Target not detected
CAB/RPV Cabotegravir/rilpivirine
TAF Tenofovir alafenimide
BIC Bictegravir
BL Baseline